Aya Jakobovits

California, USA

Medical Devices, Health tech, All

Founder/ Executive of 5 Bio companies who exited a total of $15B. Former CEO of KitePharma (Gilead), Board Member at Dorian Therapeutics and Adicet Bio, Yeda R&D, UCLA Technology Development Group

Aya Jakobovits - Aya Jakobovits has over 25 years track record in starting and growing biotech companies, which developed novel technologies and therapeutic products. The companies include Adicet Bio, Inc. (Founder, President & CEO); Kite Pharma, Inc (President & Founding CEO), acquired by Gilead for $11.9 billion; Agensys, Inc. (SVP, Corporate Development & CSO), acquired by Astellas for $530 million; Abgenix, Inc. (Scientific Founder, Director, Discovery Research and Principal Scientist), Inc., acquired by Amgen Inc. for $2.2 billion. She also served as a Venture Partner at OrbiMed. She serves on the Board of Directors of Adicet Bio, Dyve Biosciences Inc., UCLA Technology Development Corporation, and Yeda Research and Development Co. Ltd. Dr. Jakobovits received her B.Sc. cum laude from the Hebrew university of Jerusalem, her M.Sc. in Chemistry and Ph.D. in Life Sciences from the Weizmann Institute of Sciences, Israel, and was a postdoctoral fellow at UCSF and Genentech. Dr. Jakobovits is an author of over 50 scientific publications and inventor of over 120 issued patents.